Vital Farms, Inc. $VITL Stock Position Lifted by Citigroup Inc.

Citigroup Inc. lifted its position in Vital Farms, Inc. (NASDAQ:VITL) by 554.1% in the 3rd quarter, Holdings Channel.com reports. The fund owned 95,258 shares of the company’s stock after acquiring an additional 80,694 shares during the period. Citigroup Inc.’s holdings in Vital Farms were worth $3,920,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in VITL. Royal Bank of Canada lifted its stake in Vital Farms by 89.2% during the first quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock worth $591,000 after purchasing an additional 9,136 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Vital Farms by 5.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock worth $611,000 after buying an additional 1,108 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Vital Farms by 3.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock worth $12,658,000 after buying an additional 13,397 shares during the last quarter. Woodline Partners LP acquired a new position in shares of Vital Farms in the 1st quarter valued at about $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Vital Farms by 1.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock valued at $2,739,000 after buying an additional 1,198 shares during the last quarter. 98.59% of the stock is owned by institutional investors and hedge funds.

Vital Farms Stock Down 1.4%

VITL opened at $20.01 on Thursday. The stock’s 50 day moving average price is $27.85 and its 200 day moving average price is $35.48. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.16 and a quick ratio of 1.61. The stock has a market cap of $896.45 million, a P/E ratio of 13.90 and a beta of 1.14. Vital Farms, Inc. has a 12 month low of $19.75 and a 12 month high of $53.13.

Vital Farms (NASDAQ:VITL) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.03). The business had revenue of $213.55 million during the quarter, compared to the consensus estimate of $212.83 million. Vital Farms had a return on equity of 20.69% and a net margin of 8.73%.The company’s revenue for the quarter was up 28.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.23 EPS. As a group, research analysts predict that Vital Farms, Inc. will post 1.11 earnings per share for the current year.

Analysts Set New Price Targets

VITL has been the topic of a number of recent research reports. Mizuho cut their target price on shares of Vital Farms from $48.00 to $40.00 and set an “outperform” rating on the stock in a report on Monday. Needham & Company LLC cut their price target on Vital Farms from $45.00 to $35.00 and set a “buy” rating on the stock in a report on Monday. TD Cowen restated a “buy” rating on shares of Vital Farms in a research report on Tuesday, January 20th. Weiss Ratings restated a “hold (c+)” rating on shares of Vital Farms in a research note on Monday, December 29th. Finally, Benchmark cut Vital Farms from a “buy” rating to a “hold” rating in a research note on Thursday, February 26th. Nine analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $45.00.

Vital Farms News Summary

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Analysts’ consensus still shows some support — a recent aggregator noted a “Moderate Buy” consensus from analysts, which could provide buying interest if sentiment stabilizes. Analyst Consensus: Moderate Buy
• Positive Sentiment: Some Wall Street commentary highlights bulls and reasons to consider the stock, which may attract opportunistic investors if shares overshoot to the downside. Wall Street Bulls Look Optimistic
• Neutral Sentiment: Insider transaction — major shareholder Matthew Ohayer sold 20,000 shares at about $20.33 (≈$406.6K). The sale is small relative to his ~6.32M share holding (≈0.32% reduction), so it’s a modest signal rather than a large forced liquidation. SEC Filing: Insider Sale
• Negative Sentiment: Rosen Law Firm announced a securities‑class‑action investigation alleging Vital Farms may have provided materially misleading information to investors — such probes can increase legal risk, potential liabilities and near‑term headline volatility. Rosen Law Firm Investigation
• Negative Sentiment: Zacks Research downgraded Vital Farms from “Hold” to “Strong Sell,” which can accelerate outflows from model‑based funds and momentum traders. Zacks Downgrade
• Negative Sentiment: Broker downgrades and lowered forecasts — Needham and Mizuho have reduced expectations for Vital Farms, and Benchmark cut to Hold and removed its price target after the company issued a “volatile” Q1 outlook. These analyst moves increase sell‑side pressure and signal uncertainty around near‑term revenue/earnings momentum. Needham Outlook
• Negative Sentiment: Mizuho lowered expectations as well, compounding the negative analyst trend and likely contributing to shorter‑term downside. Mizuho Lowers Expectations
• Negative Sentiment: Benchmark’s downgrade tied to a cautious Q1 outlook — the firm cited tempered FY26 revenue growth and removed its price target, reinforcing recessionary/volume risk concerns that can pressure valuation multiples. Benchmark Downgrade

Insider Transactions at Vital Farms

In other news, insider Matthew Ohayer sold 25,000 shares of the stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $30.85, for a total value of $771,250.00. Following the completion of the transaction, the insider directly owned 6,361,190 shares in the company, valued at $196,242,711.50. This trade represents a 0.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Russell Diez-Canseco sold 16,734 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $35.05, for a total value of $586,526.70. Following the sale, the chief executive officer directly owned 649,684 shares in the company, valued at approximately $22,771,424.20. The trade was a 2.51% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 86,734 shares of company stock valued at $2,498,827 in the last quarter. 21.30% of the stock is currently owned by insiders.

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.